A recent systematic review showed that PCa patients commonly experience symptoms related to FCR and prostate-specific antigen (PSA), such as anxiety, which significantly impact their mental health and overall quality of life [14]. This evidence concerns the gene KLK3 and posterior cortical atrophy.